Resperate

Resperate and its parent company 2breathe Technologies Ltd. are pioneers in the development of digital therapeutics. RESPeRATE, which was initially used to naturally lower blood pressure, is now also effective in alleviating insomnia. Their original product, RESPeRATE®, is the world’s first FDA-approved non-drug treatment device for hypertension. It is currently being used by tens of thousands of patients worldwide and has been featured in the American Heart Association's statement on non-pharmacological treatments.